Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.51)
# 3,087
Out of 5,056 analysts
69
Total ratings
47.5%
Success rate
-10.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Overweight | $6 → $5 | $2.17 | +130.41% | 7 | Nov 11, 2025 | |
| AMWL American Well | Maintains: Overweight | $12 → $9 | $4.02 | +123.88% | 5 | Nov 5, 2025 | |
| VEEV Veeva Systems | Maintains: Overweight | $326 → $341 | $273.72 | +24.58% | 8 | Aug 28, 2025 | |
| DOCS Doximity | Maintains: Equal-Weight | $62 → $65 | $47.42 | +37.07% | 12 | Aug 8, 2025 | |
| OMCL Omnicell | Maintains: Overweight | $37 → $40 | $34.42 | +16.21% | 17 | Jul 21, 2025 | |
| TDOC Teladoc Health | Maintains: Equal-Weight | $10 → $8 | $7.00 | +14.29% | 3 | May 8, 2025 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $7 | $2.79 | +150.90% | 8 | Apr 29, 2025 | |
| HQY HealthEquity | Maintains: Overweight | $110 → $125 | $102.74 | +21.67% | 9 | Feb 26, 2025 |
Health Catalyst
Nov 11, 2025
Maintains: Overweight
Price Target: $6 → $5
Current: $2.17
Upside: +130.41%
American Well
Nov 5, 2025
Maintains: Overweight
Price Target: $12 → $9
Current: $4.02
Upside: +123.88%
Veeva Systems
Aug 28, 2025
Maintains: Overweight
Price Target: $326 → $341
Current: $273.72
Upside: +24.58%
Doximity
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $62 → $65
Current: $47.42
Upside: +37.07%
Omnicell
Jul 21, 2025
Maintains: Overweight
Price Target: $37 → $40
Current: $34.42
Upside: +16.21%
Teladoc Health
May 8, 2025
Maintains: Equal-Weight
Price Target: $10 → $8
Current: $7.00
Upside: +14.29%
GoodRx Holdings
Apr 29, 2025
Maintains: Overweight
Price Target: $8 → $7
Current: $2.79
Upside: +150.90%
HealthEquity
Feb 26, 2025
Maintains: Overweight
Price Target: $110 → $125
Current: $102.74
Upside: +21.67%